Back to search

Belgium· BE-AMP-SAM588284-00

Deferasirox AB 360 mg

A deferasirox product containing deferasirox, registered in Belgium by Aurobindo. The same ATC class is registered in 18 of our 19 countries.

ATC V03AC03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDeferasirox AB 360 mgATCV03AC03REGISTER NO.BE-AMP-SAM588284-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Deferasirox is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Deferasirox · ATC V03AC03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferasirox costs, country by country.

Normalised to the WHO defined daily dose (0.98 g), the median price runs from $24.11 in Spain to $59.57 in Switzerland — a ×2.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Deferasirox · price per daily dose (0.98 g)

USD · FX 28 Sept 2026

  • CH Switzerland$59.57
  • IT Italy$43.21
  • FR France$27.16
  • ES Spain$24.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Deferasirox
Manufacturer
Aurobindo
Country
Belgium (BE)
ATC code
V03AC03
ATC class
Deferasirox
Defined daily dose
0.98 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7733959
  • be_apb
    4430922

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

616 interactions on record for deferasirox.

Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Deferasirox · interactions on record

616 records

  • 205 severe
  • 399 moderate
  • 12 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferasirox in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferasirox products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Deferasirox G.L., Deferasirox Ratiopharm
  • Bulgaria · Deferasirox Synthon, Ziadex
  • Cyprus · Deferasirox Msn, Issoferrol
  • Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
  • Germany · Deferasi Puren, Deferasirox Abdi
  • Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
  • Spain · Deferasirox Abdi, Deferasirox Aurovitas
  • Finland · Deferasirox Glenmark, Deferasirox Stada
  • France · Deferasirox Arrow, Deferasirox Bgr
  • United Kingdom (Northern Ireland) · Deferasirox Abdi Farma, Deferasirox Amarox
  • Greece · Deferasirox Pharmathen, Deferasirox Rafarm
  • Croatia · Deferasiroks Pliva, Deferasiroks Umedica
  • Hungary · Deferasirox Msn, Deferasirox Pharmascience
  • Iceland · Deferasirox Accord, Deferasirox Medical Valley
  • Italy · Deferasirox Abdi, Deferasirox Aurobindo
  • Liechtenstein · Deferasirox Accord, Deferasirox Mylan
  • Latvia · Deferasirox Umedica
  • Malta · Deferasirox Pharos
  • Netherlands · Deferasirox Abdi, Deferasirox Amarox
  • Norway · Deferasirox Accord, Deferasirox Medical Valley
  • Poland · Deferasirox Msn, Exferana
  • Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
  • Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
  • Sweden · Deferasirox Glenmark, Deferasirox Jubilant
  • Slovakia · Deferasirox, Deferasirox Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1ac074b-4772-47c0-ae68-33189cc4946d
GET /v1/drugs/e1ac074b-4772-47c0-ae68-33189cc4946d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Deferasirox AB 360 mg",
  "name_fr": "Deferasirox AB 360 mg",
  "name_nl": "Deferasirox AB 360 mg",
  "amp_code": "SAM588284-00",
  "strengths": [
    "360.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Deferasirox"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Deferasirox",
  "authorisation_numbers": [
    "BE588284",
    "BE588293"
  ]
}

See everything about deferasirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.